{
  "id": 3643,
  "text": ", et al.Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: , et al.Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "该临床试验研究了顺铂（cisplatin）和异环磷酰胺（ifosfamide），并评估了是否加入紫杉醇（paclitaxel）对复发或转移性宫颈癌治疗的效果。该研究由希腊肿瘤协作组（Hellenic Cooperative Oncology Group，HeCOG）负责进行。",
  "query": "这个临床试验研究了哪些化疗药物在治疗复发或转移性宫颈癌方面的效果，并且是什么组织负责进行该项研究？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这个临床试验研究了哪些化疗药物在治疗复发或转移性宫颈癌方面的效果，并且是什么组织负责进行该项研究？\n\n<reference text>: , et al.Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "该临床试验研究了顺铂（cisplatin）和异环磷酰胺（ifosfamide），并评估了是否加入紫杉醇（paclitaxel）对复发或转移性宫颈癌治疗的效果。该研究由希腊肿瘤协作组（Hellenic Cooperative Oncology Group，HeCOG）负责进行。"
}